Advanced Medicine

What is the single greatest challenge facing the cell and gene therapy industry in 2021?

High-level purification maximizes the amount of therapeutic gene payload being delivered with each vector to reduce the risk of immune reaction.

In this eBook, experts give their views on enhancing downstream purification.

DNA manufacturers must pick up the pace to support the genetic medicine revolution.

Experts from our previous Power Lists discuss the challenges of leadership during these trying times.

We Sit Down With Sandy Macrae, Chief Executive Officer, Sangamo Therapeutics, USA.

Everything cell + gene therapy – in five minutes.

Mice with severed spinal cords walk again after gene therapy.

Facilities must be flexible enough to cope with multiple modalities, including cell and gene therapies.

Big Data opens the door to even smarter cell therapies.